US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 0.940
- -0.056-5.59%
Close Nov 27 16:00 ET
67.04MMarket Cap-4087P/E (TTM)
1.070High0.912Low70.27KVolume0.995Open0.996Pre Close68.97KTurnover1.34%Turnover RatioLossP/E (Static)71.30MShares49.00052wk High1.39P/B4.94MFloat Cap0.85052wk Low--Dividend TTM5.25MShs Float49.000Historical High--Div YieldTTM15.87%Amplitude0.850Historical Low0.981Avg Price1Lot Size
Citius Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash, cash equivalents and short term investments | --0 | --0 |
| -Cash and cash equivalents | --0 | --0 |
| Prepaid assets | 187.52%7.73M | --2.69M |
| Total current assets | 187.52%7.73M | --2.69M |
| Non current assets | ||
| Goodwill and other intangible assets | 0.00%40M | --40M |
| -Other intangible assets | 0.00%40M | --40M |
| Total non current assets | 0.00%40M | --40M |
| Total assets | 11.82%47.73M | --42.69M |
| Liabilities | ||
| Current liabilities | ||
| Payables | 334.36%20.79M | --4.79M |
| -accounts payable | 1,296.42%1.29M | --92.31K |
| -Due to related parties current | 315.44%19.5M | --4.69M |
| Current accrued expenses | -75.58%259.07K | --1.06M |
| Current liabilities | 259.98%21.05M | --5.85M |
| Non current liabilities | ||
| Non current deferred liabilities | 100.00%1.15M | --576K |
| Total non current liabilities | 100.00%1.15M | --576K |
| Total liabilities | 245.63%22.2M | --6.42M |
| Shareholders'equity | ||
| Share capital | 0.00%6.75K | --6.75K |
| -common stock | 0.00%6.75K | --6.75K |
| -Preferred stock | --0 | --0 |
| Retained earnings | -233.72%-18.13M | ---5.43M |
| Paid-in capital | 4.71%43.66M | --41.69M |
| Total stockholders'equity | -29.59%25.54M | --36.27M |
| Total equity | -29.59%25.54M | --36.27M |
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
